Paolo Antonio Ascierto

InstitutionIstituto Nazionale Tumori Fondazione Pascale
AddressNaples
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 23 Covid-19 publications, with a maximum of 3 publications in October 2020 and March 2021
    All Publications
    Bar chart showing 347 publications over 25 distinct years, with a maximum of 42 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Vannucchi AM, Mortara A, D'Alessio A, Morelli M, Tedeschi A, Festuccia MB, Monforte AD, Capochiani E, Selleri C, Simonetti F, Saracino A, Rapezzi D, Badagliacca MR, Falasca K, Molteni A, Palazzolo R, Schettino G, Bocchia M, Turrini M, Ascierto PA, Zuurman M, Paley C, Coco P, Saglio G. JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy. J Clin Med. 2021 Aug 23; 10(16). PMID: 34442045.
      Citations: 1     
    2. Madonna G, Sale S, Capone M, De Falco C, Santocchio V, Di Matola T, Fiorentino G, Pirozzi C, D'Antonio A, Sabatino R, Atripaldi L, Atripaldi U, Raffone M, Curvietto M, Grimaldi AM, Vanella V, Festino L, Scarpato L, Palla M, Spatarella M, Perna F, Cerino P, Botti G, Parrella R, Montesarchio V, Ascierto PA, Atripaldi L. Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes' iTNF-a Expression. Biology (Basel). 2021 Aug 01; 10(8). PMID: 34439967.
      Citations:    
    3. Ascierto PA, Fu B, Wei H. IL-6 modulation for COVID-19: the right patients at the right time? J Immunother Cancer. 2021 04; 9(4). PMID: 33837054.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    4. Isgrò MA, Vitale MG, Celentano E, Nocerino F, Porciello G, Curvietto M, Mallardo D, Montagnese C, Russo L, Zanaletti N, Avallone A, Pensabene M, De Laurentiis M, Centonze S, Pignata S, Cannella L, Morabito A, Caponigro F, Botti G, Masucci GV, Giannarelli D, Cavalcanti E, Ascierto PA. Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis. J Transl Med. 2021 03 31; 19(1):132. PMID: 33789686.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    5. Atripaldi L, Sale S, Capone M, Montesarchio V, Parrella R, Botti G, Ascierto PA, Madonna G. Could asymptomatic carriers spread the SARS-CoV-2 infection? Experience from the Italian second wave. J Transl Med. 2021 03 02; 19(1):93. PMID: 33653336.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    6. Goldman JD, Ascierto PA. Perspectives on COVID-19 and cancer immunotherapy: a review series. J Immunother Cancer. 2021 03; 9(3). PMID: 33688023.
      Citations: 1     Fields:    Translation:Humans
    7. Trojaniello C, Vitale MG, Ascierto PA. Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19. Ann Oncol. 2021 05; 32(5):674-676. PMID: 33600920.
      Citations: 1     Fields:    Translation:Humans
    8. Mandala M, Lorigan P, De Luca M, Bianchetti A, Merelli B, Bettini AC, Bonomi L, Nahm S, Vitale MG, Negrini G, Di Croce A, Ascierto PA, Rulli E, Tondini CA. SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study. J Immunother Cancer. 2021 02; 9(2). PMID: 33593827.
      Citations: 6     Fields:    Translation:Humans
    9. Cerino P, Coppola A, Volzone P, Pizzolante A, Pierri B, Atripaldi L, Zollo M, Capasso M, Ascierto PA, Triassi M, Brambilla G, Perrella A, Bruzzese D, Buonerba C. Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): a population-based study. Future Sci OA. 2021 Jan 12; 7(4):FSO673. PMID: 33815819.
      Citations: 4     
    10. Citations: 6     Fields:    Translation:Humans
    11. Scarpa R, Caso F, Costa L, Passavanti S, Vitale MG, Trojaniello C, Del Puente A, Ascierto PA. May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)? J Transl Med. 2020 12 22; 18(1):489. PMID: 33353549.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    12. Miscio L, Olivieri A, Labonia F, De Feo G, Chiodini P, Portella G, Atripaldi L, Parrella R, Conenna R, Buonaguro FM, Cavalcanti E, Ascierto P, Botti G, Bianchi A. Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection. J Transl Med. 2020 12 21; 18(1):488. PMID: 33349261.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    13. Buonaguro FM, Botti G, Ascierto PA, Pignata S, Ionna F, Delrio P, Petrillo A, Cavalcanti E, Di Bonito M, Perdonà S, De Laurentiis M, Fiore F, Palaia R, Izzo F, D'Auria S, Rossi V, Menegozzo S, Piccirillo M, Celentano E, Cuomo A, Normanno N, Tornesello ML, Saviano R, Barberio D, Buonaguro L, Giannoni G, Muto P, Miscio L, Bianchi AAM. The clinical and translational research activities at the INT - IRCCS "Fondazione Pascale" cancer center (Naples, Italy) during the COVID-19 pandemic. Infect Agent Cancer. 2020 Nov 23; 15(1):69. PMID: 33292365.
      Citations:    
    14. Citations: 29     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    15. Piccirillo MC, Ascierto P, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo N, Fraganza F, Marata A, Massari M, Montesarchio V, Mussini C, Negri EA, Parrella R, Popoli P, Botti G, Arenare L, Chiodini P, Gallo C, Salvarani C, Perrone F. TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol. Contemp Clin Trials. 2020 11; 98:106165. PMID: 33031955.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    16. Ottaviano M, Curvietto M, Rescigno P, Tortora M, Palmieri G, Giannarelli D, Aieta M, Assalone P, Attademo L, Avallone A, Bloise F, Bosso D, Borzillo V, Buono G, Calderoni G, Caputo F, Cartenì G, Cavallero D, Cavo A, Ciardiello F, Conca R, Conteduca V, De Falco S, De Felice M, De Laurentiis M, De Placido P, De Placido S, De Santo I, De Stefano A, Della Corte CM, Di Franco R, Di Lauro V, Fabbrocini A, Federico P, Festino L, Giordano P, Giuliano M, Gridelli C, Grimaldi AM, Lia M, Marretta AL, Massa V, Mennitto A, Merler S, Merz V, Messina C, Messina M, Milano M, Minisini AM, Montesarchio V, Morabito A, Morgillo F, Mucci B, Nappi L, Napolitano F, Paciolla I, Pagliuca M, Palmieri G, Parola S, et al. Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists. J Immunother Cancer. 2020 10; 8(2). PMID: 33060148.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    17. Bernardo L, Del Sesto S, Giordano L, Benincaso AR, Biondi P, Goj V, Ferrara F, Talenti A, Grisolia A, Ascierto PA. Severe prolonged neutropenia following administration of tocilizumab in a patient affected by COVID-19: a case report and brief review of the literature. Drugs Ther Perspect. 2020; 36(12):568-572. PMID: 32952393.
      Citations: 1     
    18. Montesarchio V, Parrela R, Iommelli C, Bianco A, Manzillo E, Fraganza F, Palumbo C, Rea G, Murino P, De Rosa R, Atripaldi L, D'Abbraccio M, Curvietto M, Mallardo D, Celentano E, Grimaldi AM, Palla M, Trojaniello C, Vitale MG, Million-Weaver SL, Ascierto PA. Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy. J Immunother Cancer. 2020 08; 8(2). PMID: 32784217.
      Citations: 34     Fields:    Translation:HumansCellsPHPublic Health
    19. Cascella M, Mauro I, De Blasio E, Crispo A, Del Gaudio A, Bimonte S, Cuomo A, Ascierto PA. Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS. Medicina (Kaunas). 2020 Jul 27; 56(8). PMID: 32727107.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    20. Buonaguro FM, Ascierto PA, Morse GD, Buonaguro L, Puzanov I, Tornesello ML, Bréchot C, Gallo RC. Covid-19: Time for a paradigm change. Rev Med Virol. 2020 09; 30(5):e2134. PMID: 32618072.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    21. Arnaldez FI, O'Day SJ, Drake CG, Fox BA, Fu B, Urba WJ, Montesarchio V, Weber JS, Wei H, Wigginton JM, Ascierto PA. The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response. J Immunother Cancer. 2020 05; 8(1). PMID: 32385146.
      Citations: 40     Fields:    Translation:HumansCellsPHPublic Health
    22. Buonaguro FM, Puzanov I, Ascierto PA. Anti-IL6R role in treatment of COVID-19-related ARDS. J Transl Med. 2020 04 14; 18(1):165. PMID: 32290847.
      Citations: 39     Fields:    Translation:HumansCellsPHPublic Health
    23. Ascierto PA, Fox BA, Urba WJ, Anderson AC, Atkins MB, Borden EC, Brahmer JR, Butterfield LH, Cesano A, Chen DC, de Gruijl TD, Dillman RO, Drake CG, Emens LA, Gajewski TF, Gulley JL, Stephen Hodi FJ, Hwu P, Kaufman D, Kaufman HL, Lotze MT, McNeel DG, Margolin KM, Marincola FM, Mastrangelo MJ, Maus MV, Parkinson DR, Romero PJ, Sondel PM, Spranger S, Sznol M, Weiner GJ, Wigginton JM, Weber JS. Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19. J Immunother Cancer. 2020 04; 8(1). PMID: 32300051.
      Citations: 36     Fields:    Translation:HumansCellsPHPublic Health
    Ascierto's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (334)
    Explore
    _
    Co-Authors (360)
    Explore
    _
    Similar People (60)
    Explore
    _